Scientific Steering Committee

The purpose of the LCRF Scientific Steering Committee is to support the mission of the Foundation by providing guidance and review of the scientific grant program and its outcomes. The Steering Committee also helps to ensure that the Foundation’s history is considered when potential changes to the scientific grant program are evaluated. Membership consists of individuals from a variety of backgrounds, research areas, and career levels to help ensure LCRF receives input from all reaches of the research community.

Scientific Steering Committee Members

Joan Schiller, MD (Chair)

LCRF Board of Directors
Deputy Director for Clinical Research
Chief, Hematology/Oncology
Inova Schar Cancer Institute
Professor, Department of Medicine
Virginia Commonwealth University

Jan Baranski, PhD

Director, Scientific Programs, LCRF

Meryl Bralower

Patient Advocate

James B. Dougherty, MD

LCRF Board of Directors
General Partner, Arcus Ventures

Katerina Politi, PhD

Associate Professor of Pathology
Yale School of Medicine

Suresh S. Ramalingam, MD

Professor of Hematology and Medical Oncology
Director of Medical Oncology
Roberto C. Goizueta Chair in Cancer Research
Deputy Director, Winship Cancer Institute
Assistant Dean for Cancer Research
Emory University School of Medicine

Naiyer Rizvi, MD

Professor of Medicine
Director of Thoracic Oncology and Phase I Immunotherapeutics
Price Chair in Clinical Translational Research
Columbia University Medical Center

Jill Siegfried, PhD

Professor and Head, Department of Pharmacology
Frederick and Alice Stark Endowed Chair
Associate Director for Translation, Masonic Cancer Center
University of Minnesota Medical School

David Spigel, MD

Chief Scientific Officer
Sarah Cannon Research Institute

Brendon Stiles, MD

LCRF Board of Directors
Associate Professor of Cardiothoracic Surgery
Weill Cornell Medical College